BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20663868)

  • 1. Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region.
    Rana S; Baranski TJ
    J Biol Chem; 2010 Oct; 285(41):31472-83. PubMed ID: 20663868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
    Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
    J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural mechanisms of constitutive activation in the C5a receptors with mutations in the extracellular loops: molecular modeling study.
    Nikiforovich GV; Baranski TJ
    Proteins; 2012 Jan; 80(1):71-80. PubMed ID: 21960464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role for the second extracellular loop in C5a receptor activation.
    Klco JM; Wiegand CB; Narzinski K; Baranski TJ
    Nat Struct Mol Biol; 2005 Apr; 12(4):320-6. PubMed ID: 15768031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
    Hagemann IS; Narzinski KD; Floyd DH; Baranski TJ
    J Biol Chem; 2006 Dec; 281(48):36783-92. PubMed ID: 17023413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
    Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W
    Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation and endocytosis of the complement factor 5a receptor: evidence for multiple activated conformations of a G protein-coupled receptor.
    Whistler JL; Gerber BO; Meng EC; Baranski TJ; von Zastrow M; Bourne HR
    Traffic; 2002 Dec; 3(12):866-77. PubMed ID: 12453150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
    Gustavsson M; Dyer DP; Zhao C; Handel TM
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective coupling of the human anaphylatoxin C5a receptor and alpha 16 in human kidney 293 cells.
    Buhl AM; Eisfelder BJ; Worthen GS; Johnson GL; Russell M
    FEBS Lett; 1993 May; 323(1-2):132-4. PubMed ID: 8388335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
    Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
    J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
    Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
    J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
    Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
    Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.
    Wescott MP; Kufareva I; Paes C; Goodman JR; Thaker Y; Puffer BA; Berdougo E; Rucker JB; Handel TM; Doranz BJ
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9928-33. PubMed ID: 27543332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis by substituted cysteine scanning mutagenesis of the fourth transmembrane domain of the CXCR4 receptor in its inactive and active state.
    Boulais PE; Escher E; Leduc R
    Biochem Pharmacol; 2013 Feb; 85(4):541-50. PubMed ID: 23219524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway.
    Braun L; Christophe T; Boulay F
    J Biol Chem; 2003 Feb; 278(6):4277-85. PubMed ID: 12464600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activation.
    Valentin-Hansen L; Holst B; Frimurer TM; Schwartz TW
    J Biol Chem; 2012 Dec; 287(52):43516-26. PubMed ID: 23135271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
    Zhang WB; Navenot JM; Haribabu B; Tamamura H; Hiramatu K; Omagari A; Pei G; Manfredi JP; Fujii N; Broach JR; Peiper SC
    J Biol Chem; 2002 Jul; 277(27):24515-21. PubMed ID: 11923301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An activation switch in the ligand binding pocket of the C5a receptor.
    Gerber BO; Meng EC; Dotsch V; Baranski TJ; Bourne HR
    J Biol Chem; 2001 Feb; 276(5):3394-400. PubMed ID: 11062244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.